NanoString
UBS Initiates Coverage of 10X Genomics, PacBio, Akoya Biosciences, NanoString Technologies
The investment bank gave 10X Genomics and PacBio a Neutral rating, and Akoya and NanoString a Buy rating.
NanoString Technologies, Weill Cornell Medicine Collaborate on Spatial Atlas of Human Tissues
Shares of the Seattle-based genomics firm rose as much as 9 percent in Thursday morning trading on the Nasdaq and were up 12 percent over the last two days.
JP Morgan Healthcare Conference, Day 3: Invitae, NanoString, Bio-Rad, Olink, More
Highlights from the third day included Invitae's plans for its testing business and updates on instrument placements by NanoString Technologies and Olink.
Preliminary Earnings Roundup: NanoString Technologies, SomaLogic, Pacific Biosciences, More
Other firms reporting their preliminary earnings for Q4 included Akoya Biosciences, Olink, Standard BioTools, and Singular Genomics.
GenomeWeb Top 40 Down 3 Percent in December, Though More Resilient Than Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq fell 9 percent, and the Nasdaq Biotech Index was down 3 percent.